Approval Isn’t the Finish Line: Maximizing Product Potential with Harris Kaplan

Fidelity’s Healthcare Investments Across Three Generations: WSJ’s Justin Baer

The Race to Protect Newborns: Dr. Howard Berman on HIE

Biotech as a Strategic Asset: Dr. Jeremy Levin on Science, Policy, and Public Trust

Public Health Is Public Wealth: Dr. Michelle Williams on Why Prevention Pays

The New Dynamics of Hospitals: What Leaders Need to Know with Scott Becker

The First Venture Fund for Paralysis: SCI Ventures Founder Adrien Cohen

AI, Data, and Venture Capital: Sahir Ali on Smarter Biotech Investing

Curing Corneal Blindness: Dr. Edward Holland on the Cincinnati Protocol

Behind the Byline: What Journalists Look for When Covering Biotech

Early Detection Matters: Insights into Alzheimer's Treatments and Caregiving

Why Baby Guts Hold the Key: Dr. Stephanie Culler on the Power of the Microbiome

Coya Therapeutics moves from IND clearance to Phase 2 in ALS research

From Songwriter to Patient Champion: Dana Parish on Giving Millions a Voice

Driving Innovation in Wound Healing: Inside BioStem with Jason Matuszewski

Rethinking Hydration with Microwearables: A Conversation with WearOptimo’s Mark Kendall

Solomon Wilcots Talks NFL, Pickleball, and the APP NYC Open on Fox 5’s “Sports Xtra”

Caregiving, Memory, and Hope: A Conversation with Novelist Muffy Walker

Investor Ready: Sara Jane Demy on Connection, Capital, and CEO Conversations

The Intersection of Sports and Health: Football Icons Shaun O’Hara, Ed McCaffrey, and Alex Smith

The Neuroscience Behind ALS Solutions: A Conversation with Dr. Shiran Zimri

From Research to Reality: Insights from Dr. Paul Wotton

David Bearss, CEO, Halia Therapeutics

Transforming Bone Marrow Transplants: Kevin Caldwell at Ossium Health

Jill Pellegrino, CEO of AutoCruitment

From Lab to Boardroom: The Leadership Edge’s Gaylene Xanthopoulos on CEO Strategies

Biotech Horizons: Industry Evolution, Q4 Outlook, and Key Catalysts with Graig Suvannavejh

Revolutionizing Medicine with Cell Therapy: Brian Culley, CEO of Lineage Cell Therapeutics

Pete O'Heeron, CEO of FibroBiologics

Rob Etherington, CEO of Clene Nanomedicine

BETx 2024: BioEngineering in Paris

Employee Engagement in BioTech and Pharma

Simon Arkell, Ryght

David Bearss, Halia Therapeutics

Sean Bohen, Olema Oncology

WPLG TV Gaumard Ventilator Training

Russo Partners' Sports-Health Alliance PSA: “Stay Safe. Stay Together. Stay Healthy."